Europe Medical Enzymes Market 2022-2028

Increased R&D investments are expected to fuel the market for medical enzymes in Europe

MARKET OUTLOOK

The publisher's study on the medical enzymes market in Europe estimates that it would grow in revenue, with a 6.12% CAGR over the forecasting years 2022-2028. Spain, the United Kingdom, Italy, France, Germany, and Rest of Europe are assessed in the market in this region.

In Germany, cancer and cardiovascular diseases are two leading causes for mortality. Besides, obesity is also a rising concern. The in-vitro diagnostics (IVD) devices are used to detect cancer, cardiovascular diseases, gastrointestinal diseases, and infections for early diagnosis and treatment. Healthcare is affordable in the country and out-of-pocket spending by Germans is low.

The demand for IVD is growing due to the rising prevalence of these diseases. The research and development projects related to IVD and other advanced techniques are expected to influence the demand for medical enzymes. This, in turn, will drive the studied market’s growth in the forthcoming years.

In 2018, chronic diseases were responsible for 92% of the total number of deaths in Spain, with the majority of them being cancers and cardiovascular diseases, as per estimates from the National Library of Medicine. Most of these deaths were attributable to behavioral risk factors, such as low physical activity, dietary risks, alcohol consumption, and tobacco smoking, among others. The rising occurrence of chronic diseases is thus expected to drive the demand for medical enzymes, and thereby foster the growth of the market during the forecast period.

COMPETITIVE OUTLOOK

The primary contenders in the medical enzymes market include Novozymes, Brain Biotech AG, DSM, Advanced Enzymes, DuPont, Amano Enzyme, Roche Holding AG, and Codexis.

1. Europe Medical Enzymes Market - Summary

2. Industry Outlook

2.1. Impact of Covid-19 on the Medical Enzymes Market
2.2. Key Insights
2.2.1. Advancements in Enzyme Engineering
2.2.2. Increased Demand in the Pharmaceutical Sector
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Key Impact Analysis
2.4.1. Price
2.4.2. Quality
2.4.3. Usage
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Industry Components
2.7.1. Research and Development
2.7.2. Operations
2.7.3. Outbound Logistics
2.8. Regulatory Framework
2.9. Key Market Strategies
2.9.1. Mergers & Acquisitions
2.9.2. Product Launches & Developments
2.9.3. Partnerships & Agreements
2.9.4. Business Expansions & Divestitures
2.10. Market Drivers
2.10.1. Rising Investments in Research and Development
2.10.2. Rising Aging Population and Occurrence of Chronic Diseases
2.10.3. Increasing Application in the Pharmaceutical Industry
2.11. Market Challenges
2.11.1. Strict Regulations
2.11.2. Safety Concerns while Handling Enzymes
2.12. Market Opportunities
2.12.1. Rising Health Issues and Growing Awareness
2.12.2. Rising Demand for Specialty Enzymes

3. Europe Medical Enzymes Market Outlook - by Product Type

3.1. Hydrolase
3.1.1. Hyaluronidase
3.1.2. Lysozymes
3.1.3. Other Hydrolases Enzymes
3.2. Thrombolytic Enzyme
3.2.1. Streptokinase
3.2.2. Urokinase
3.2.3. Other Thrombolytic Enzymes
3.3. Digestive Enzyme
3.3.1. Lactase
3.3.2. L-Asparaginase
3.3.3. Other Digestive Enzymes
3.4. Endonuclease
3.4.1. Benzonase
3.4.2. Other Endonucleases

4. Europe Medical Enzymes Market Outlook - by Application

4.1. Disease Treatment
4.2. Diagnostic Tools
4.3. Biomedical Research
4.4. Other Applications

5. Europe Medical Enzymes Market - Country Outlook

5.1. United Kingdom
5.2. Germany
5.3. France
5.4. Spain
5.5. Italy
5.6. Rest of Europe

6. Competitive Landscape

6.1. Basf Se
6.2. Dupont
6.3. Roche Holding AG
6.4. Novozymes
6.5. Dsm
6.6. Sanofi Sa
6.7. Codexis
6.8. Advanced Enzymes
6.9. Amano Enzyme
6.10. Bbi Solutions
6.11. Thermofisher Scientific Inc
6.12. Cpc Biotech
6.13. Novus
6.14. Brain Biotech AG
6.15. Sekisui

7. Research Methodology & Scope

7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

List of Tables

Table 1: Europe Medical Enzymes Market, by Country, 2022-2028 (In $ Million)
Table 2: Applications of Enzymes in the Pharmaceuticals Industry
Table 3: Vendor Scorecard
Table 4: Regulatory Framework
Table 5: List of Mergers & Acquisitions
Table 6: List of Product Launches & Developments
Table 7: List of Partnerships & Agreements
Table 8: List of Business Expansions & Divestitures
Table 9: Medical Application of Various Enzymes
Table 10: Europe Medical Enzymes Market, by Product Type, 2022-2028 (In $ Million)
Table 11: Europe Medical Enzymes Market, by Hydrolase Enzyme, 2022-2028 (In $ Million)
Table 12: Europe Medical Enzymes Market, by Thrombolytic Enzyme, 2022-2028 (In $ Million)
Table 13: Europe Medical Enzymes Market, by Digestive Enzyme, 2022-2028 (In $ Million)
Table 14: Europe Medical Enzymes Market, by Endonuclease, 2022-2028 (In $ Million)
Table 15: Europe Medical Enzymes Market, by Application, 2022-2028 (In $ Million)
Table 16: Europe Medical Enzymes Market, by Country, 2022-2028 (In $ Million)

List of Figures

Figure 1: Key Buying Impact Analysis
Figure 2: Market Attractiveness Index
Figure 3: Industry Components
Figure 4: Europe Medical Enzymes Market, by Product Type, 2021 & 2028 (In %)
Figure 5: Europe Medical Enzymes Market, by Hydrolase, 2022-2028 (In $ Million)
Figure 6: Europe Medical Enzymes Market, by Hydrolase Enzyme, 2021 & 2028 (In %)
Figure 7: Europe Medical Enzymes Market, by Hyaluronidase, 2022-2028 (In $ Million)
Figure 8: Europe Medical Enzymes Market, by Lysozymes, 2022-2028 (In $ Million)
Figure 9: Europe Medical Enzymes Market, by Other Hydrolases Enzymes, 2022-2028 (In $ Million)
Figure 10: Europe Medical Enzymes Market, by Thrombolytic Enzyme, 2022-2028 (In $ Million)
Figure 11: Europe Medical Enzymes Market, by Thrombolytic Enzyme, 2021 & 2028 (In %)
Figure 12: Europe Medical Enzymes Market, by Streptokinase, 2022-2028 (In $ Million)
Figure 13: Europe Medical Enzymes Market, by Urokinase, 2022-2028 (In $ Million)
Figure 14: Europe Medical Enzymes Market, by Other Thrombolytic Enzymes, 2022-2028 (In $ Million)
Figure 15: Europe Medical Enzymes Market, by Digestive Enzyme, 2022-2028 (In $ Million)
Figure 16: Europe Medical Enzymes Market, by Digestive Enzyme, 2021 & 2028 (In %)
Figure 17: Europe Medical Enzymes Market, by Lactase, 2022-2028 (In $ Million)
Figure 18: Europe Medical Enzymes Market, by L-Asparaginase, 2022-2028 (In $ Million)
Figure 19: Europe Medical Enzymes Market, by Other Digestive Enzymes, 2022-2028 (In $ Million)
Figure 20: Europe Medical Enzymes Market, by Endonuclease, 2022-2028 (In $ Million)
Figure 21: Europe Medical Enzymes Market, by Endnuclease Enzyme, 2021 & 2028 (In %)
Figure 22: Europe Medical Enzymes Market, by Benzonase, 2022-2028 (In $ Million)
Figure 23: Europe Medical Enzymes Market, by Other Endonucleases, 2022-2028 (In $ Million)
Figure 24: Europe Medical Enzymes Market, by Application, 2021 & 2028 (In %)
Figure 25: Europe Medical Enzymes Market, by Disease Treatment, 2022-2028 (In $ Million)
Figure 26: Europe Medical Enzymes Market, by Diagnostic Tools, 2022-2028 (In $ Million)
Figure 27: Europe Medical Enzymes Market, by Biomedical Research, 2022-2028 (In $ Million)
Figure 28: Europe Medical Enzymes Market, by Other Applications, 2022-2028 (In $ Million)
Figure 29: Europe Medical Enzymes Market, Country Outlook, 2021 & 2028 (In %)
Figure 30: United Kingdom Medical Enzymes Market, 2022-2028 (In $ Million)
Figure 31: Germany Medical Enzymes Market 2022-2028 (In $ Million)
Figure 32: France Medical Enzymes Market 2022-2028 (In $ Million)
Figure 33: Spain Medical Enzymes Market 2022-2028 (In $ Million)
Figure 34: Italy Medical Enzymes Market 2022-2028 (In $ Million)
Figure 35: Rest of Europe Medical Enzymes Market 2022-2028 (In $ Million)